Success Metrics

Clinical Success Rate
100.0%

Based on 15 completed trials

Completion Rate
100%(15/15)
Active Trials
0(0%)
Results Posted
13%(2 trials)

Phase Distribution

Ph phase_3
4
25%
Ph phase_4
5
31%
Ph not_applicable
4
25%
Ph phase_1
2
13%
Ph phase_2
1
6%

Phase Distribution

2

Early Stage

1

Mid Stage

9

Late Stage

Phase Distribution16 total trials
Phase 1Safety & dosage
2(12.5%)
Phase 2Efficacy & side effects
1(6.3%)
Phase 3Large-scale testing
4(25.0%)
Phase 4Post-market surveillance
5(31.3%)
N/ANon-phased studies
4(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

15 of 15 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

16

all time

Status Distribution
Completed(15)
Other(1)

Detailed Status

Completed15
unknown1

Development Timeline

Analytics

Development Status

Total Trials
16
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (12.5%)
Phase 21 (6.3%)
Phase 34 (25.0%)
Phase 45 (31.3%)
N/A4 (25.0%)

Trials by Status

completed1594%
unknown16%

Recent Activity

Clinical Trials (16)

Showing 16 of 16 trials
NCT02389374Phase 4

A Study to Assess Safety of Current Standard Malaria Treatment and an Assessment of G6PD Status in South-east Bangladesh

Completed
NCT01845701Phase 3

Artemisinin-Based Antimalarial Combinations and Clinical Response in Cameroon

Completed
NCT02411994Phase 3

Pyronaridine-artesunate and Artemether-lumefantrine for the Treatment of Paediatric Malaria

Completed
NCT02600767Not Applicable

Artemether-lumefantrine for Treatment of P. Falciparum Malaria in Brazil

Completed
NCT02001012Phase 3

P. Knowlesi Trial of Artemether-lumefantrine vs Chloroquine

Completed
NCT01680406Phase 4

Ethiopia Antimalarial in Vivo Efficacy Study 2012

Completed
NCT02242799Phase 1

Dolutegravir Interactions With Artemisinin-based Combination Therapies

Completed
NCT01651416Phase 4

Seasonal Malaria Chemoprevention Versus Home Management of Malaria in Children Under 5 Years in Ghana

Completed
NCT01935882Phase 2

Low Dose Primaquine for Clearance of Gametocytes

Completed
NCT01939886Phase 3

Treatment Efficacy and Malaria TRANSmission After Artemisinin Combination Therapy 2 (TRANSACT2)

Completed
NCT01603251Phase 1

Trial of Artemether-Lumefantrine Alone and in Combination With Ivermectin to Reduce Post-Treatment Malaria Transmission

Completed
NCT01326754Not Applicable

Efficacy of Artemether-lumefantrine, Artesunate-amodiaquine and Dihydroartemisinin-piperaquine for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in Malawi

Completed
NCT01575613Not Applicable

Reducing the Burden of Malaria by Targeting Hotspots of Malaria Transmission

Completed
NCT01599000Phase 4

Artemether-Lumefantrine Clinical Effectiveness Study

Completed
NCT00720811Not Applicable

Assessment of Use of Rapid Diagnostic Testing in the Context of Home Management With ACTs

Completed
NCT01038063Phase 4

Safety and Effectiveness of Artemisinin-based Combination Therapies (ACTs) With Repeated Treatments for Uncomplicated Falciparum Malaria Over a Three-year Period

Unknown

All 16 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
16